Posts

Description amendments can extend protection (T 439/22)

The validity and value of cell therapy safety protocol inventions (T 1555/23)

Never Too Late: If you missed the IPKat last week!

[Guest Post] Ceci n’est pas du Gruyère: Swiss origin claims and how to deal with them

[Guest post] Retromark Volume XVII: the last six months in trade marks

The never-ending story of Brexit – The Final Chapter

Tuesday Tiddlywinks

[UPCKat] 2025 UPC cases and outcomes: What do the numbers say?

Accounts of profits & threats: Luxe World v Touch of Vogue

Saturday Sundries

Never Too Late: If you missed the IPKat last week!

Skating between human magic and machine, the fragile fate of generative AI ‘works’

[Guest Post] What the Inari vs. Corteva case really tells us about enablement of plant inventions